Nova Patents
ATE264671T1

Methods for (in vivo) delivery of biologics and compositions useful therefor

Abstract

In accordance with the present invention, novel formulations have been developed which are much more effective for the delivery of hydrophobic drugs to patients in need thereof than are prior art formulations. Invention formulations are capable of delivering more drug in shorter periods of time, with reduced side effects caused by the pharmaceutical carrier employed for delivery.

Term

Term ended

Projected expiry passed 22 February 2014, 12.6 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

233 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
2369893United States of AmericaA
3515093United States of AmericaA
9401985United States of AmericaW

Members233

Family members, oldest first
DocumentOfficeKind
CA2155947A1CanadaA1
WO9418954A1World Intellectual Property Organization (WIPO)A1
AU6249094AAustraliaA
US5362478AUnited States of AmericaA
US5439686AUnited States of AmericaA
NO953278D0NorwayD0
NO953278LNorwayL
BR9405798ABrazilA
EP0693924A1European Patent Office (EPO)A1
CN1118136AChinaA
US5498421AUnited States of AmericaA
US5505932AUnited States of AmericaA
US5508021AUnited States of AmericaA
US5512268AUnited States of AmericaA
JPH08507075AJapanA
US5560933AUnited States of AmericaA
AU673057B2AustraliaB2
US5635207AUnited States of AmericaA
US5639473AUnited States of AmericaA
US5650156AUnited States of AmericaA
EP0693924A4European Patent Office (EPO)A4
NZ262679ANew ZealandA
US5665382AUnited States of AmericaA
US5665383AUnited States of AmericaA
CA2267498A1CanadaA1
CA2512487A1CanadaA1
WO9814174A1World Intellectual Property Organization (WIPO)A1
WO9814175A1World Intellectual Property Organization (WIPO)A1
AU4592997AAustraliaA
AU4661097AAustraliaA
CA2294981A1CanadaA1
CA2765222A1CanadaA1
WO9900113A1World Intellectual Property Organization (WIPO)A1
AU8266298AAustraliaA
NO991620D0NorwayD0
WO9900113A9World Intellectual Property Organization (WIPO)A9
NO991620LNorwayL
US5916596AUnited States of AmericaA
US5997904AUnited States of AmericaA
CN1237901AChinaA
EP0961612A1European Patent Office (EPO)A1
NO996433D0NorwayD0
NO20120338A1NorwayA1
NO996433LNorwayL
AU718753B2AustraliaB2
US6096331AUnited States of AmericaA
EP1023050A1European Patent Office (EPO)A1
CN1267214AChinaA
HK1024866A1Hong Kong, ChinaA1
CA2684454A1CanadaA1
CA2371912A1CanadaA1
WO0071079A2World Intellectual Property Organization (WIPO)A2
AU5035900AAustraliaA
NZ335133ANew ZealandA
JP2001501931AJapanA
KR20010014254ARepublic of KoreaA
IL133672D0IsraelD0
HK1030543A1Hong Kong, ChinaA1
HU0003972A2HungaryA2
HUP0003972A2HungaryA2
BR9711856ABrazilA
WO0189522A1World Intellectual Property Organization (WIPO)A1
AU6322901AAustraliaA
BR9810945ABrazilA
EP1178786A1European Patent Office (EPO)A1
JP2002507976AJapanA
NZ502500ANew ZealandA
HU0003972A3HungaryA3
HUP0003972A3HungaryA3
CA2446083A1CanadaA1
WO02087545A1World Intellectual Property Organization (WIPO)A1
HK1045646A1Hong Kong, ChinaA1
US6506405B1United States of AmericaB1
NO314017B1NorwayB1
US6528067B1United States of AmericaB1
US6537579B1United States of AmericaB1
US2003068362A1United States of AmericaA1
US2003073642A1United States of AmericaA1
US2003133955A1United States of AmericaA1
EP1337249A1European Patent Office (EPO)A1
US2003199425A1United States of AmericaA1
WO03096944A1World Intellectual Property Organization (WIPO)A1
AU2003229084A1AustraliaA1
EP1390014A1European Patent Office (EPO)A1
MXPA03010085AMexicoA
IL158178D0IsraelD0
EP1337249A4European Patent Office (EPO)A4
EP0693924B1European Patent Office (EPO)B1
AT264671TAustriaT
ATE264671T1This recordAustriaT1
DE69433723D1GermanyD1
US6749868B1United States of AmericaB1
US6753006B1United States of AmericaB1
CN1157185CChinaC
CN1515244AChinaA
CN1515246AChinaA
DK0693924T3DenmarkT3
NZ525580ANew ZealandA
PT693924EPortugalE
ES2219646T3SpainT3
Showing 100 of 233